MedicarePartD.guide

A non-government resource built from CMS public data

Ubrelvy on SilverScript Choice (S5601-044)

ubrogepant

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 16 per 30 days.

$330.65
Patient pays / month, after deductible
$834.95
Patient pays / month, before the $615.00 deductible
$991.94
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

UBRELVY 50 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $1,836.93 for a month. Other covered strengths are listed below.

Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
FormTierPatient pays / monthLimits
UBRELVY 50 mg Tablet3$330.65PA · 16 per 30 days
UBRELVY 100 mg Tablet3$330.67PA · 16 per 30 days

Other CGRP migraine drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-044